Last 12 months
Inside the activity.
0 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 19, 2021 Filed May 21, 2021 20:37 UTC |
WEHRWEIN SVENDirector
|
GrantCommon Stock | 910 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034938 · doc4.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,820 F1 · shares: The deferred stock units will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the reporting person remains a member of the board as of the vesting date. The deferred stock units must be retained until completion of the reporting person's service on the board, and upon completion of such service, convert into an equal number of shares of our common stock. The reporting person may defer receipt of the shares for up to ten years after completion of service. Read SEC document |
| May 19, 2021 Filed May 21, 2021 20:35 UTC |
Ward Anne SempowskiDirector
|
GrantStock Option (right to buy) · Derivative | 2,778 | $0.00 Strike: $93.40 | $0.00 |
DisclosureSEC source: 0001209191-21-034933 · doc4.xml · derivative · entry 2 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,778 Underlying: Common Stock · 2,778 shares Expires 2028-05-19 F2 · derivative.exercise_date: This option shall vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the reporting person remains a member of the board as of the vesting date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 20:35 UTC |
Ward Anne SempowskiDirector
|
GrantCommon Stock | 910 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034933 · doc4.xml · nonDerivative · entry 1 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 910 F1 · shares: This reflects a restricted stock award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the recipient remains a member of the board as of the vesting date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 20:31 UTC |
SORAN PHILIPDirector
|
GrantStock Option (right to buy) · Derivative | 2,778 | $0.00 Strike: $93.40 | $0.00 |
DisclosureSEC source: 0001209191-21-034920 · doc4.xml · derivative · entry 2 SORAN PHILIP · CIK 0001233126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,778 Underlying: Common Stock · 2,778 shares Expires 2028-05-19 F2 · derivative.exercise_date: This option shall vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the reporting person remains a member of the board as of the vesting date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 20:31 UTC |
SORAN PHILIPDirector
|
GrantCommon Stock | 910 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034920 · doc4.xml · nonDerivative · entry 1 SORAN PHILIP · CIK 0001233126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,820 F1 · shares: This reflects a restricted stock award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the recipient remains a member of the board as of the vesting date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 20:29 UTC |
Reller TamiDirector
|
GrantStock Option (right to buy) · Derivative | 2,778 | $0.00 Strike: $93.40 | $0.00 |
DisclosureSEC source: 0001209191-21-034916 · doc4.xml · derivative · entry 2 Reller Tami · CIK 0001582737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,778 Underlying: Common Stock · 2,778 shares Expires 2028-05-19 F2 · derivative.exercise_date: This option shall vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the reporting person remains a member of the board as of the vesting date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 20:29 UTC |
Reller TamiDirector
|
GrantCommon Stock | 910 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034916 · doc4.xml · nonDerivative · entry 1 Reller Tami · CIK 0001582737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,660 F1 · shares: This reflects a restricted stock award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the recipient remains a member of the board as of the vesting date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 20:18 UTC |
Reaume Marty MDirector
|
GrantStock Option (right to buy) · Derivative | 2,778 | $0.00 Strike: $93.40 | $0.00 |
DisclosureSEC source: 0001209191-21-034903 · doc4.xml · derivative · entry 2 Reaume Marty M · CIK 0001735354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,778 Underlying: Common Stock · 2,778 shares Expires 2028-05-19 F2 · derivative.exercise_date: This option shall vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the reporting person remains a member of the board as of the vesting date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 20:18 UTC |
Reaume Marty MDirector
|
GrantCommon Stock | 910 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034903 · doc4.xml · nonDerivative · entry 1 Reaume Marty M · CIK 0001735354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,816 F1 · shares: This reflects a restricted stock award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the recipient remains a member of the board as of the vesting date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 20:17 UTC |
Ramsey James BurrDirector
|
GrantStock Option (right to buy) · Derivative | 2,778 | $0.00 Strike: $93.40 | $0.00 |
DisclosureSEC source: 0001209191-21-034900 · doc4.xml · derivative · entry 2 Ramsey James Burr · CIK 0001456221 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,778 Underlying: Common Stock · 2,778 shares Expires 2028-05-19 F2 · derivative.exercise_date: This option shall vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the reporting person remains a member of the board as of the vesting date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 20:17 UTC |
Ramsey James BurrDirector
|
GrantCommon Stock | 910 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034900 · doc4.xml · nonDerivative · entry 1 Ramsey James Burr · CIK 0001456221 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,814 F1 · shares: This reflects a restricted stock award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the recipient remains a member of the board as of the vesting date. Read SEC document |
| May 19, 2021 Filed May 26, 2021 01:04 UTC Amendment |
WEHRWEIN SVENDirector
|
GrantStock Option (right to buy) · Derivative | 2,860 | $0.00 Strike: $93.40 | $0.00 |
DisclosureSEC source: 0001209191-21-035834 · doc4a.xml · derivative · entry 2 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,860 Underlying: Common Stock · 2,860 shares Expires 2028-05-19 F2 · shares: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. F3 · derivative.exercise_date: This option shall vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the reporting person remains a member of the board as of the vesting date. F2 · derivative.underlying_shares: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. F2 · balance_after: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. Read SEC document |
| May 19, 2021 Filed May 26, 2021 01:04 UTC Amendment |
WEHRWEIN SVENDirector
|
GrantCommon Stock | 936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035834 · doc4a.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,846 F1 · shares: The deferred stock units will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the reporting person remains a member of the board as of the vesting date. The deferred stock units must be retained until completion of the reporting person's service on the board, and upon completion of such service, convert into an equal number of shares of our common stock. The reporting person may defer receipt of the shares for up to ten years after completion of service. F2 · shares: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. Read SEC document |
| May 19, 2021 Filed May 26, 2021 01:03 UTC Amendment |
Ward Anne SempowskiDirector
|
GrantStock Option (right to buy) · Derivative | 2,860 | $0.00 Strike: $93.40 | $0.00 |
DisclosureSEC source: 0001209191-21-035832 · doc4a.xml · derivative · entry 2 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,860 Underlying: Common Stock · 2,860 shares Expires 2028-05-19 F2 · shares: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. F3 · derivative.exercise_date: This option shall vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the reporting person remains a member of the board as of the vesting date. F2 · derivative.underlying_shares: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. F2 · balance_after: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. Read SEC document |
| May 19, 2021 Filed May 26, 2021 01:03 UTC Amendment |
Ward Anne SempowskiDirector
|
GrantCommon Stock | 936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035832 · doc4a.xml · nonDerivative · entry 1 Ward Anne Sempowski · CIK 0001790117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 936 F1 · shares: This reflects a restricted stock award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the recipient remains a member of the board as of the vesting date. F2 · shares: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. Read SEC document |
| May 19, 2021 Filed May 26, 2021 01:02 UTC Amendment |
SORAN PHILIPDirector
|
GrantStock Option (right to buy) · Derivative | 2,860 | $0.00 Strike: $93.40 | $0.00 |
DisclosureSEC source: 0001209191-21-035830 · doc4a.xml · derivative · entry 2 SORAN PHILIP · CIK 0001233126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,860 Underlying: Common Stock · 2,860 shares Expires 2028-05-19 F2 · shares: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. F3 · derivative.exercise_date: This option shall vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the reporting person remains a member of the board as of the vesting date. F2 · derivative.underlying_shares: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. F2 · balance_after: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. Read SEC document |
| May 19, 2021 Filed May 26, 2021 01:02 UTC Amendment |
SORAN PHILIPDirector
|
GrantCommon Stock | 936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035830 · doc4a.xml · nonDerivative · entry 1 SORAN PHILIP · CIK 0001233126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,846 F1 · shares: This reflects a restricted stock award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the recipient remains a member of the board as of the vesting date. F2 · shares: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. Read SEC document |
| May 19, 2021 Filed May 26, 2021 01:01 UTC Amendment |
Reller TamiDirector
|
GrantStock Option (right to buy) · Derivative | 2,860 | $0.00 Strike: $93.40 | $0.00 |
DisclosureSEC source: 0001209191-21-035828 · doc4a.xml · derivative · entry 2 Reller Tami · CIK 0001582737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,860 Underlying: Common Stock · 2,860 shares Expires 2028-05-19 F2 · shares: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. F3 · derivative.exercise_date: This option shall vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the reporting person remains a member of the board as of the vesting date. F2 · derivative.underlying_shares: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. F2 · balance_after: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. Read SEC document |
| May 19, 2021 Filed May 26, 2021 01:01 UTC Amendment |
Reller TamiDirector
|
GrantCommon Stock | 936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035828 · doc4a.xml · nonDerivative · entry 1 Reller Tami · CIK 0001582737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,686 F1 · shares: This reflects a restricted stock award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the recipient remains a member of the board as of the vesting date. F2 · shares: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. Read SEC document |
| May 19, 2021 Filed May 26, 2021 00:59 UTC Amendment |
Reaume Marty MDirector
|
GrantStock Option (right to buy) · Derivative | 2,860 | $0.00 Strike: $93.40 | $0.00 |
DisclosureSEC source: 0001209191-21-035825 · doc4a.xml · derivative · entry 2 Reaume Marty M · CIK 0001735354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,860 Underlying: Common Stock · 2,860 shares Expires 2028-05-19 F2 · shares: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. F3 · derivative.exercise_date: This option shall vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the reporting person remains a member of the board as of the vesting date. F2 · derivative.underlying_shares: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. F2 · balance_after: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. Read SEC document |
| May 19, 2021 Filed May 26, 2021 00:59 UTC Amendment |
Reaume Marty MDirector
|
GrantCommon Stock | 936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035825 · doc4a.xml · nonDerivative · entry 1 Reaume Marty M · CIK 0001735354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,842 F1 · shares: This reflects a restricted stock award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the recipient remains a member of the board as of the vesting date. F2 · shares: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. Read SEC document |
| May 19, 2021 Filed May 26, 2021 00:58 UTC Amendment |
Ramsey James BurrDirector
|
GrantStock Option (right to buy) · Derivative | 2,860 | $0.00 Strike: $93.40 | $0.00 |
DisclosureSEC source: 0001209191-21-035824 · doc4a.xml · derivative · entry 2 Ramsey James Burr · CIK 0001456221 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,860 Underlying: Common Stock · 2,860 shares Expires 2028-05-19 F2 · shares: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. F3 · derivative.exercise_date: This option shall vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the reporting person remains a member of the board as of the vesting date. F2 · derivative.underlying_shares: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. F2 · balance_after: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. Read SEC document |
| May 19, 2021 Filed May 26, 2021 00:58 UTC Amendment |
Ramsey James BurrDirector
|
GrantCommon Stock | 936 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035824 · doc4a.xml · nonDerivative · entry 1 Ramsey James Burr · CIK 0001456221 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,840 F1 · shares: This reflects a restricted stock award. The shares subject to this award will vest in four equal installments on the last day of each fiscal quarter with the first vesting occurring on June 30, 2021, provided the recipient remains a member of the board as of the vesting date. F2 · shares: This amendment corrects the amounts reported on Form 4 filed on May 21, 2021. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 20:15 UTC |
Nelson Kimberly K.EVP & CFO
|
SaleCommon Stock | 300 | $108.31 | $32,492.01 |
DisclosureSEC source: 0001209191-21-020448 · doc4.xml · nonDerivative · entry 3 Nelson Kimberly K. · CIK 0001489097 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,602 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020 and modified on December 9, 2020. F4 · price: Reflects the weighted average price of 300 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on March 11, 2021 with sales prices ranging from $108.28 to $108.36 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 20:15 UTC |
Nelson Kimberly K.EVP & CFO
|
SaleCommon Stock | 1,724 | $107.86 | $185,946.67 |
DisclosureSEC source: 0001209191-21-020448 · doc4.xml · nonDerivative · entry 2 Nelson Kimberly K. · CIK 0001489097 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,902 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020 and modified on December 9, 2020. F3 · price: Reflects the weighted average price of 1,724 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on March 11, 2021 with sales prices ranging from $107.26 to $108.24 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 20:15 UTC |
Nelson Kimberly K.EVP & CFO
|
SaleCommon Stock | 3,976 | $106.73 | $424,346.55 |
DisclosureSEC source: 0001209191-21-020448 · doc4.xml · nonDerivative · entry 1 Nelson Kimberly K. · CIK 0001489097 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,626 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020 and modified on December 9, 2020. F2 · price: Reflects the weighted average price of 3,976 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on March 11, 2021 with sales prices ranging from $106.25 to $107.20 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:13 UTC |
Frome James J.EVP & Chief Operating Officer
|
SaleCommon Stock | 1,323 | $103.34 | $136,721.20 |
DisclosureSEC source: 0001209191-21-015872 · doc4.xml · nonDerivative · entry 12 Frome James J. · CIK 0001489265 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,963 F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F14 · price: Reflects the weighted average price of 1,323 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on March 1, 2021 with sales prices ranging from $103.19 to $103.39 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:13 UTC |
Frome James J.EVP & Chief Operating Officer
|
SaleCommon Stock | 3,979 | $102.62 | $408,324.98 |
DisclosureSEC source: 0001209191-21-015872 · doc4.xml · nonDerivative · entry 11 Frome James J. · CIK 0001489265 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,286 F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F13 · price: Reflects the weighted average price of 3,979 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on March 1, 2021 with sales prices ranging from $102.17 to $103.11 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:13 UTC |
Frome James J.EVP & Chief Operating Officer
|
SaleCommon Stock | 933 | $101.70 | $94,883.95 |
DisclosureSEC source: 0001209191-21-015872 · doc4.xml · nonDerivative · entry 10 Frome James J. · CIK 0001489265 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,265 F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F12 · price: Reflects the weighted average price of 933 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on March 1, 2021 with sales prices ranging from $101.13 to $102.09 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| March 01, 2021 Filed Mar 2, 2021 21:13 UTC |
Frome James J.EVP & Chief Operating Officer
|
SaleCommon Stock | 500 | $100.57 | $50,283.00 |
DisclosureSEC source: 0001209191-21-015872 · doc4.xml · nonDerivative · entry 9 Frome James J. · CIK 0001489265 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,198 F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F11 · price: Reflects the weighted average price of 500 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on March 1, 2021 with sales prices ranging from $100.11 to $101.08 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:08 UTC |
Black Archie C.Director · CEO
|
SaleCommon Stock | 1,064 | $103.21 | $109,812.25 |
DisclosureSEC source: 0001209191-21-017190 · doc4.xml · nonDerivative · entry 4 Black Archie C. · CIK 0001489095 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,463 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2020. F5 · price: Reflects the weighted average price of 1,064 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on March 1, 2021 with sales prices ranging from $103.08 to $103.37 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:08 UTC |
Black Archie C.Director · CEO
|
SaleCommon Stock | 6,839 | $102.57 | $701,487.86 |
DisclosureSEC source: 0001209191-21-017190 · doc4.xml · nonDerivative · entry 3 Black Archie C. · CIK 0001489095 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,527 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2020. F4 · price: Reflects the weighted average price of 6,839 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on March 1, 2021 with sales prices ranging from $102.05 to $103.01 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:08 UTC |
Black Archie C.Director · CEO
|
SaleCommon Stock | 30,996 | $101.69 | $3,151,986.34 |
DisclosureSEC source: 0001209191-21-017190 · doc4.xml · nonDerivative · entry 2 Black Archie C. · CIK 0001489095 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,366 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2020. F3 · price: Reflects the weighted average price of 30,996 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on March 1, 2021 with sales prices ranging from $101.05 to $101.98 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:08 UTC |
Black Archie C.Director · CEO
|
SaleCommon Stock | 4,500 | $100.50 | $452,249.55 |
DisclosureSEC source: 0001209191-21-017190 · doc4.xml · nonDerivative · entry 1 Black Archie C. · CIK 0001489095 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,362 F1 · kind: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2020. F2 · price: Reflects the weighted average price of 4,500 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on March 1, 2021 with sales prices ranging from $100.03 to $101.02 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:13 UTC |
Frome James J.EVP & Chief Operating Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 28,290 | $0.00 Strike: $27.37 | $0.00 |
DisclosureSEC source: 0001209191-21-015872 · doc4.xml · derivative · entry 16 Frome James J. · CIK 0001489265 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,432 Underlying: Common Stock · 28,290 shares Expires 2025-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: This option was previously reported as an option for 18,861 shares of Common stock at an exercise price of $54.68 per share, but was adjusted to reflect the stock dividend declared by the Issuer on July 25, 2019. F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F5 · shares: This option was previously reported as an option for 18,861 shares of Common stock at an exercise price of $54.68 per share, but was adjusted to reflect the stock dividend declared by the Issuer on July 25, 2019. F17 · derivative.exercise_date: Options vest as to 25% of the shares on February 13, 2019. The remaining shares vest in a series of 36 successive equal monthly installments upon completion of each additional month of service (commencing on March 13, 2019). F5 · derivative.underlying_shares: This option was previously reported as an option for 18,861 shares of Common stock at an exercise price of $54.68 per share, but was adjusted to reflect the stock dividend declared by the Issuer on July 25, 2019. F5 · balance_after: This option was previously reported as an option for 18,861 shares of Common stock at an exercise price of $54.68 per share, but was adjusted to reflect the stock dividend declared by the Issuer on July 25, 2019. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:13 UTC |
Frome James J.EVP & Chief Operating Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,056 | $0.00 Strike: $54.54 | $0.00 |
DisclosureSEC source: 0001209191-21-015872 · doc4.xml · derivative · entry 15 Frome James J. · CIK 0001489265 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,058 Underlying: Common Stock · 10,056 shares Expires 2026-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: This option was previously reported as an option for 10,057 shares of Common stock at an exercise price of $109.07 per share, but was adjusted to reflect the stock dividend declared by the Issuer on July 25, 2019. F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F3 · shares: This option was previously reported as an option for 10,057 shares of Common stock at an exercise price of $109.07 per share, but was adjusted to reflect the stock dividend declared by the Issuer on July 25, 2019. F16 · derivative.exercise_date: Options vest as to 25% of the shares on February 19, 2020. The remaining shares vest in a series of 36 successive equal monthly installments upon completion of each additional month of service (commencing on March 19, 2020). F3 · derivative.underlying_shares: This option was previously reported as an option for 10,057 shares of Common stock at an exercise price of $109.07 per share, but was adjusted to reflect the stock dividend declared by the Issuer on July 25, 2019. F3 · balance_after: This option was previously reported as an option for 10,057 shares of Common stock at an exercise price of $109.07 per share, but was adjusted to reflect the stock dividend declared by the Issuer on July 25, 2019. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:13 UTC |
Frome James J.EVP & Chief Operating Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,124 | $0.00 Strike: $27.85 | $0.00 |
DisclosureSEC source: 0001209191-21-015872 · doc4.xml · derivative · entry 14 Frome James J. · CIK 0001489265 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,124 shares Expires 2024-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F15 · derivative.exercise_date: Fully vested. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:13 UTC |
Frome James J.EVP & Chief Operating Officer
|
SaleCommon Stock | 802 | $103.71 | $83,177.67 |
DisclosureSEC source: 0001209191-21-015872 · doc4.xml · nonDerivative · entry 8 Frome James J. · CIK 0001489265 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,698 F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F10 · price: Reflects the weighted average price of 802 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on February 26, 2021 with sales prices ranging from $103.68 to $103.94 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:13 UTC |
Frome James J.EVP & Chief Operating Officer
|
SaleCommon Stock | 2,632 | $103.18 | $271,557.39 |
DisclosureSEC source: 0001209191-21-015872 · doc4.xml · nonDerivative · entry 7 Frome James J. · CIK 0001489265 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,500 F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F9 · price: Reflects the weighted average price of 2,632 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on February 26, 2021 with sales prices ranging from $102.68 to $103.61 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:13 UTC |
Frome James J.EVP & Chief Operating Officer
|
SaleCommon Stock | 15,066 | $101.90 | $1,535,184.72 |
DisclosureSEC source: 0001209191-21-015872 · doc4.xml · nonDerivative · entry 6 Frome James J. · CIK 0001489265 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,132 F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F8 · price: Reflects the weighted average price of 15,066 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on February 26, 2021 with sales prices ranging from $101.62 to $102.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:13 UTC |
Frome James J.EVP & Chief Operating Officer
|
SaleCommon Stock | 38,771 | $101.10 | $3,919,856.66 |
DisclosureSEC source: 0001209191-21-015872 · doc4.xml · nonDerivative · entry 5 Frome James J. · CIK 0001489265 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,198 F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F7 · price: Reflects the weighted average price of 38,771 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on February 26, 2021 with sales prices ranging from $100.62 to $101.61 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:13 UTC |
Frome James J.EVP & Chief Operating Officer
|
SaleCommon Stock | 2,400 | $99.58 | $238,993.68 |
DisclosureSEC source: 0001209191-21-015872 · doc4.xml · nonDerivative · entry 4 Frome James J. · CIK 0001489265 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,969 F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F6 · price: Reflects the weighted average price of 2,400 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on February 26, 2021 with sales prices ranging from $99.5800 to $99.5814 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:13 UTC |
Frome James J.EVP & Chief Operating Officer
|
Exercise / conversionCommon Stock | 28,290 | $27.37 | $774,297.30 |
DisclosureSEC source: 0001209191-21-015872 · doc4.xml · nonDerivative · entry 3 Frome James J. · CIK 0001489265 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,369 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F4 · shares: On July 25, 2019, the Issuer announced that its board of directors declared a two-for-one stock split of the Common Stock of the Issuer, effected in the form of a 100 percent stock dividend as of the record date on August 8, 2019. The stock split dividend was distributed on August 22, 2019, and at that time pursuant to anti-dilution provisions of the Issuer's 2010 Equity Incentive Plan, an option for 18,861 shares of Common Stock held by the reporting person on August 22, 2019 became an option for 37,722 shares of Common Stock. F5 · shares: This option was previously reported as an option for 18,861 shares of Common stock at an exercise price of $54.68 per share, but was adjusted to reflect the stock dividend declared by the Issuer on July 25, 2019. F4 · price: On July 25, 2019, the Issuer announced that its board of directors declared a two-for-one stock split of the Common Stock of the Issuer, effected in the form of a 100 percent stock dividend as of the record date on August 8, 2019. The stock split dividend was distributed on August 22, 2019, and at that time pursuant to anti-dilution provisions of the Issuer's 2010 Equity Incentive Plan, an option for 18,861 shares of Common Stock held by the reporting person on August 22, 2019 became an option for 37,722 shares of Common Stock. F5 · price: This option was previously reported as an option for 18,861 shares of Common stock at an exercise price of $54.68 per share, but was adjusted to reflect the stock dividend declared by the Issuer on July 25, 2019. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:13 UTC |
Frome James J.EVP & Chief Operating Officer
|
Exercise / conversionCommon Stock | 10,056 | $54.54 | $548,454.24 |
DisclosureSEC source: 0001209191-21-015872 · doc4.xml · nonDerivative · entry 2 Frome James J. · CIK 0001489265 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F2 · shares: On July 25, 2019, the Issuer announced that its board of directors declared a two-for-one stock split of the Common Stock of the Issuer, effected in the form of a 100 percent stock dividend as of the record date on August 8, 2019. The stock split dividend was distributed on August 22, 2019, and at that time pursuant to anti-dilution provisions of the Issuer's 2010 Equity Incentive Plan, an option for 10,057 shares of Common Stock held by the reporting person on August 22, 2019 became an option for 20,114 shares of Common Stock. F3 · shares: This option was previously reported as an option for 10,057 shares of Common stock at an exercise price of $109.07 per share, but was adjusted to reflect the stock dividend declared by the Issuer on July 25, 2019. F2 · price: On July 25, 2019, the Issuer announced that its board of directors declared a two-for-one stock split of the Common Stock of the Issuer, effected in the form of a 100 percent stock dividend as of the record date on August 8, 2019. The stock split dividend was distributed on August 22, 2019, and at that time pursuant to anti-dilution provisions of the Issuer's 2010 Equity Incentive Plan, an option for 10,057 shares of Common Stock held by the reporting person on August 22, 2019 became an option for 20,114 shares of Common Stock. F3 · price: This option was previously reported as an option for 10,057 shares of Common stock at an exercise price of $109.07 per share, but was adjusted to reflect the stock dividend declared by the Issuer on July 25, 2019. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:13 UTC |
Frome James J.EVP & Chief Operating Officer
|
Exercise / conversionCommon Stock | 6,124 | $27.85 | $170,553.40 |
DisclosureSEC source: 0001209191-21-015872 · doc4.xml · nonDerivative · entry 1 Frome James J. · CIK 0001489265 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:10 UTC |
Nelson Kimberly K.EVP & CFO
|
SaleCommon Stock | 1,400 | $106.31 | $148,833.02 |
DisclosureSEC source: 0001209191-21-014706 · doc4.xml · nonDerivative · entry 3 Nelson Kimberly K. · CIK 0001489097 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,602 F3 · price: Reflects the weighted average price of 1,400 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on February 25, 2021 with sales prices ranging from $105.78 to $106.77 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:10 UTC |
Nelson Kimberly K.EVP & CFO
|
SaleCommon Stock | 3,294 | $105.02 | $345,948.40 |
DisclosureSEC source: 0001209191-21-014706 · doc4.xml · nonDerivative · entry 2 Nelson Kimberly K. · CIK 0001489097 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,002 F2 · price: Reflects the weighted average price of 3,294 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on February 25, 2021 with sales prices ranging from $104.69 to $105.62 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 21:10 UTC |
Nelson Kimberly K.EVP & CFO
|
SaleCommon Stock | 3,311 | $104.17 | $344,893.63 |
DisclosureSEC source: 0001209191-21-014706 · doc4.xml · nonDerivative · entry 1 Nelson Kimberly K. · CIK 0001489097 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,296 F1 · price: Reflects the weighted average price of 3,311 shares of Common Stock of the Issuer sold by the reporting person in multiple transactions on February 25, 2021 with sales prices ranging from $103.66 to $104.65 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 21:16 UTC |
Ramsey James BurrDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,620 | $0.00 Strike: $25.87 | $0.00 |
DisclosureSEC source: 0001209191-21-014727 · doc4.xml · derivative · entry 8 Ramsey James Burr · CIK 0001456221 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,620 shares Expires 2021-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: This option was previously reported as an option for 2,810 shares of Common stock at an exercise price of $51.74 per share, but was adjusted to reflect the stock dividend declared by the Issuer on July 25, 2019. F4 · shares: This option was previously reported as an option for 2,810 shares of Common stock at an exercise price of $51.74 per share, but was adjusted to reflect the stock dividend declared by the Issuer on July 25, 2019. F9 · derivative.exercise_date: Fully vested. F4 · derivative.underlying_shares: This option was previously reported as an option for 2,810 shares of Common stock at an exercise price of $51.74 per share, but was adjusted to reflect the stock dividend declared by the Issuer on July 25, 2019. F4 · balance_after: This option was previously reported as an option for 2,810 shares of Common stock at an exercise price of $51.74 per share, but was adjusted to reflect the stock dividend declared by the Issuer on July 25, 2019. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 21:16 UTC |
Ramsey James BurrDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 11,802 | $0.00 Strike: $25.51 | $0.00 |
DisclosureSEC source: 0001209191-21-014727 · doc4.xml · derivative · entry 7 Ramsey James Burr · CIK 0001456221 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,802 shares Expires 2021-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: This option was previously reported as an option for 5,901 shares of Common stock at an exercise price of $51.01 per share, but was adjusted to reflect the stock dividend declared by the Issuer on July 25, 2019. F2 · shares: This option was previously reported as an option for 5,901 shares of Common stock at an exercise price of $51.01 per share, but was adjusted to reflect the stock dividend declared by the Issuer on July 25, 2019. F9 · derivative.exercise_date: Fully vested. F2 · derivative.underlying_shares: This option was previously reported as an option for 5,901 shares of Common stock at an exercise price of $51.01 per share, but was adjusted to reflect the stock dividend declared by the Issuer on July 25, 2019. F2 · balance_after: This option was previously reported as an option for 5,901 shares of Common stock at an exercise price of $51.01 per share, but was adjusted to reflect the stock dividend declared by the Issuer on July 25, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.